Public trial registry of the CCC-Munich

Trial WO29636

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
WO29636
World
Full title
:

a Phase III, open-Label, multicenter, randomized study of ATEZOLIZUMAB (ANTI-L1 Antibody) versus observation as adjuvant therapy in patients with PD-L1-selected, high-risk muscle-invasive bladder cancer after cystectomy

World
Responsible organization
:
Urologie MRI Ismaninger Str.22 81675 München Germany
Indications
Classification Code Description
- Other tumors
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Urologie MRI Ismaninger Str.22 81675 München Germany Magnifier